Aperio Group’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q4
$248K Sell
36,362
-6,855
-16% -$46.8K ﹤0.01% 2251
2020
Q3
$482K Buy
43,217
+15,317
+55% +$171K ﹤0.01% 1829
2020
Q2
$175K Buy
27,900
+13,516
+94% +$84.8K ﹤0.01% 2203
2020
Q1
$26K Buy
+14,384
New +$26K ﹤0.01% 2305
2019
Q3
Sell
-1,135
Closed -$3K 2879
2019
Q2
$3K Buy
+1,135
New +$3K ﹤0.01% 2907